Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 3
2006 2
2007 7
2008 3
2009 1
2010 4
2011 4
2012 6
2013 12
2014 5
2015 7
2016 10
2017 12
2018 8
2019 16
2020 13
2021 14
2022 16
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean florianamorgillo (12 results)?
Immunotherapy for head and neck cancer: Present and future.
Fasano M, Corte CMD, Liello RD, Viscardi G, Sparano F, Iacovino ML, Paragliola F, Piccolo A, Napolitano S, Martini G, Morgillo F, Cappabianca S, Ciardiello F. Fasano M, et al. Among authors: morgillo f. Crit Rev Oncol Hematol. 2022 Jun;174:103679. doi: 10.1016/j.critrevonc.2022.103679. Epub 2022 Apr 6. Crit Rev Oncol Hematol. 2022. PMID: 35395371 Free article. Review.
How I treat malignant pleural mesothelioma.
Viscardi G, Di Liello R, Morgillo F. Viscardi G, et al. Among authors: morgillo f. ESMO Open. 2020 Mar;4(Suppl 2):e000669. doi: 10.1136/esmoopen-2019-000669. ESMO Open. 2020. PMID: 32156681 Free PMC article. Review.
Role and targeting of anaplastic lymphoma kinase in cancer.
Della Corte CM, Viscardi G, Di Liello R, Fasano M, Martinelli E, Troiani T, Ciardiello F, Morgillo F. Della Corte CM, et al. Among authors: morgillo f. Mol Cancer. 2018 Feb 19;17(1):30. doi: 10.1186/s12943-018-0776-2. Mol Cancer. 2018. PMID: 29455642 Free PMC article. Review.
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis.
Viscardi G, Tralongo AC, Massari F, Lambertini M, Mollica V, Rizzo A, Comito F, Di Liello R, Alfieri S, Imbimbo M, Della Corte CM, Morgillo F, Simeon V, Lo Russo G, Proto C, Prelaj A, De Toma A, Galli G, Signorelli D, Ciardiello F, Remon J, Chaput N, Besse B, de Braud F, Garassino MC, Torri V, Cinquini M, Ferrara R. Viscardi G, et al. Among authors: morgillo f. Eur J Cancer. 2022 Dec;177:175-185. doi: 10.1016/j.ejca.2022.09.031. Epub 2022 Oct 5. Eur J Cancer. 2022. PMID: 36368251 Review.
Therapies in the pipeline for small-cell lung cancer.
Romanidou O, Imbimbo M, Mountzios G, Abidin A, Morgillo F, Califano R. Romanidou O, et al. Among authors: morgillo f. Br Med Bull. 2016 Sep;119(1):37-48. doi: 10.1093/bmb/ldw022. Epub 2016 Jun 20. Br Med Bull. 2016. PMID: 27325208 Review.
Lonafarnib in cancer therapy.
Morgillo F, Lee HY. Morgillo F, et al. Expert Opin Investig Drugs. 2006 Jun;15(6):709-19. doi: 10.1517/13543784.15.6.709. Expert Opin Investig Drugs. 2006. PMID: 16732721 Review.
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy.
Papaccio F, Della Corte CM, Viscardi G, Di Liello R, Esposito G, Sparano F, Ciardiello F, Morgillo F. Papaccio F, et al. Among authors: morgillo f. Int J Mol Sci. 2018 Nov 14;19(11):3595. doi: 10.3390/ijms19113595. Int J Mol Sci. 2018. PMID: 30441809 Free PMC article. Review.
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab.
Martini G, Ciardiello D, Dallio M, Famiglietti V, Esposito L, Corte CMD, Napolitano S, Fasano M, Gravina AG, Romano M, Loguercio C, Federico A, Maiello E, Tuccillo C, Morgillo F, Troiani T, Di Maio M, Martinelli E, Ciardiello F. Martini G, et al. Among authors: morgillo f. Int J Cancer. 2022 Aug 1;151(3):473-480. doi: 10.1002/ijc.34033. Epub 2022 Apr 29. Int J Cancer. 2022. PMID: 35429341 Free PMC article. Clinical Trial.
Emerging VEGF-receptor inhibitors for colorectal cancer.
Martinelli E, Troiani T, Morgillo F, Orditura M, De Vita F, Belli G, Ciardiello F. Martinelli E, et al. Among authors: morgillo f. Expert Opin Emerg Drugs. 2013 Mar;18(1):25-37. doi: 10.1517/14728214.2013.749856. Epub 2012 Dec 6. Expert Opin Emerg Drugs. 2013. PMID: 23216053 Review.
143 results